Výsledky vyhledávání - "arformoterol"

Akademický článek

Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment

Autor: Celli BR, Navaie M, Xu Z, Cho-Reyes S, Dembek C, Gilmer TP

Publikováno v: International Journal of COPD, Vol Volume 14, Pp 1019-1031 (2019)

Bartolome R Celli,1 Maryam Navaie,2,3 Zhun Xu,4 Soojin Cho-Reyes,2 Carole Dembek,5 Todd P Gilmer41Chronic Obstructive Pulmonary Disease Center, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA; 2Global Strategy, Advance Health

Externí odkaz: https://doaj.org/article/7608272e975147b8935230da341cfafe

Zobrazit plný text záznamu

Identification and Structural Characterization of Secondary Degradant of Arformoterol Impurity in LDPE Respules of Arformoterol Tartrate Inhalation Solution

Autor: Arun Bhutnar, Allwyn Andrandes, Anita Desai, Ajay Pangavhane, Sonali Vartak, Sachin Khapare

Publikováno v: American Journal of Analytical Chemistry. :286-301

Arformoterol (R, R) is an enantiomer of racemic formoterol, was the first long-acting beta agonist (LABA), approved by U.S. food and Drug Administration (FDA). The Arformoterol which is used for the treatment of Chronic obstructive pulmonary disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6e709b55e9ff73ad0c6081f43baa1c08
https://doi.org/10.4236/ajac.2018.95022

Zobrazit plný text záznamu

Enantioselective disposition of ( R,R )‐formoterol, ( S,S )‐formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control

Autor: Glenn A. Jacobson, Morten Hostrup, David Nichols, E. Haydn Walters, Christian Narkowicz

Publikováno v: Jacobson, G A, Hostrup, M, Narkowicz, C K, Nichols, D S & Walters, E H 2019, ' Enantioselective disposition of ( R, R )-formoterol, ( S, S )-formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control ', Drug Testing and Analysis, vol. 11, no. 7, pp. 950-956 . https://doi.org/10.1002/dta.2587

Formoterol is a long-acting beta2-adrenoceptor agonist (LABA) used for treatment of asthma and exercise-induced bronchoconstriction. Formoterol is usually administered as a racemic (rac-) mixture of (R,R)- and (S,S)-enantiomers. While formoterol is r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cd0391fdfc6a87cfb874f65834ff692
https://doi.org/10.1002/dta.2587

Zobrazit plný text záznamu

A rapid and sensitive UPLC–MS/MS method for quantitative determination of arformoterol in rat plasma, lung and trachea tissues

Autor: Jiangshuo Li, Jiuming He, Xiaowei Song, Xiaoyu Xu, Luojiao Huang, Manjiangcuo Wang, Hongbo Wu, Chenglong Sun, Zeper Abliz, Ruiping Zhang

Publikováno v: Chinese Chemical Letters. 29:1284-1286

A rapid and sensitive ultra-performance liquid chromatography-tandem mass spectrometry (UPLC–MS/MS) method was developed and fully validated for determination of arformoterol in rat plasma, lung and trachea tissues. The chromatographic separation w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2a725321cb3b8d92d9f5b0a8d612107a
https://doi.org/10.1016/j.cclet.2018.01.015

Zobrazit plný text záznamu

Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment

Autor: Maryam Navaie, Zhun Xu, Carole Dembek, Todd Gilmer, Soojin Cho-Reyes, Bartolome R. Celli

Publikováno v: International Journal of Chronic Obstructive Pulmonary Disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffdbabe2616034cb6aa29bb1d7afc43b
https://www.dovepress.com/medication-management-patterns-among-medicare-beneficiaries-with-chron-peer-reviewed-article-COPD

Zobrazit plný text záznamu

Enantioselective Chromatographic Analysis of Formoterol Fumarate using Chiral Mobile Phase Additives and Achiral Core-Shell Column

Autor: Krishnapriya Mohanraj, Pranav Pathak

A simple, robust, cost-effective, and rapid RP-HPLC method was developed for the separation of enantiomers of formoterol. The separation was achieved by the chiral mobile phase additive technique on an achiral column. Formoterol is a bronchodilator t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d4ce6029e14a17330938a23be3f0641
https://doi.org/10.26434/chemrxiv.12594173.v1

Zobrazit plný text záznamu

Long-term health-related quality-of-life and symptom response profiles with arformoterol in COPD: results from a 52-week trial

Autor: Vamsi Bollu, Nicola A. Hanania, James F. Donohue, Lauren Nelson, Michael D Stensland, Valerie Williams, Donald E. Stull

Publikováno v: International Journal of Chronic Obstructive Pulmonary Disease

James F Donohue,1 Vamsi K Bollu,2 Donald E Stull,3 Lauren M Nelson,4 Valerie SL Williams,4 Michael D Stensland,5 Nicola A Hanania6 1Department of Pulmonary Diseases and Critical Care Medicine, The University of North Carolina at Chapel Hill, Chapel H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::049b3dbe2f220a9116dd471a18c25ffd
https://doi.org/10.2147/copd.s141729

Zobrazit plný text záznamu

Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol

Autor: Michael D Stensland, Vaidyanathan Ganapathy

Publikováno v: International Journal of Chronic Obstructive Pulmonary Disease

Vaidyanathan Ganapathy,1 Michael D Stensland2 1Sunovion Pharmaceuticals Inc., Marlborough, MA, 2Agile Outcomes Research, Inc., Rochester, MN, USA Objective: Arformoterol is the (R,R)-enantiomer of formoterol. Preclinical studies suggest that it is a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e90b8648a766ba7b6c2c1814d09595f1
https://doi.org/10.2147/copd.s134145

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání